fusaric acid has been researched along with Mouth Neoplasms in 1 studies
Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.
Mouth Neoplasms: Tumors or cancer of the MOUTH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaglowski, JR | 1 |
| Stack, BC | 1 |
1 other study available for fusaric acid and Mouth Neoplasms
| Article | Year |
|---|---|
Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatin.
Topics: Aged; Antineoplastic Agents; Carboplatin; Carcinoma, Squamous Cell; Cell Proliferation; Dose-Respons | 2006 |